PharMerica Corp

PharMerica Corporation continues to be involved in litigation concerning average manufacturer price (AMP).

Effective Oct. 1, 2007, the Centers for Medicare & Medicaid Services (CMS) promulgated new rules under the Deficit Reduction Act of 2005 DRA changing the federal upper payment…

PharMerica Corporation says that a Court is expected to make a final decision over a settlement in litigation concerning average wholesale price (AWP) in February 2009.

AWP is a pricing benchmark published by First DataBank, Inc., which provides drug databases, content…